de Azevedo, R. A., Shoshan, E., Whang, S., Markel, G., Jaiswal, A. R., Liu, A., . . . Bar-Eli, M. (2020). MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. Oncoimmunology.
Chicago Stili Alıntıde Azevedo, Ricardo A., Einav Shoshan, Shanzhi Whang, Gal Markel, Ashvin R. Jaiswal, Arthur Liu, Michael A. Curran, Luiz R. Travassos, ve Menashe Bar-Eli. "MIF Inhibition As a Strategy for Overcoming Resistance to Immune Checkpoint Blockade Therapy in Melanoma." Oncoimmunology 2020.
MLA Alıntıde Azevedo, Ricardo A., et al. "MIF Inhibition As a Strategy for Overcoming Resistance to Immune Checkpoint Blockade Therapy in Melanoma." Oncoimmunology 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..